BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22898080)

  • 1. Overexpression of WW domain-containing oxidoreductase WOX1 preferentially induces apoptosis in human glioblastoma cells harboring mutant p53.
    Chiang MF; Yeh ST; Liao HF; Chang NS; Chen YJ
    Biomed Pharmacother; 2012 Sep; 66(6):433-8. PubMed ID: 22898080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Sonic hedgehog signaling and WW domain containing oxidoreductase WOX1 expression enhances radiosensitivity of human glioblastoma cells.
    Chiang MF; Chen HH; Chi CW; Sze CI; Hsu ML; Shieh HR; Lin CP; Tsai JT; Chen YJ
    Exp Biol Med (Maywood); 2015 Mar; 240(3):392-9. PubMed ID: 25595187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity.
    Chang NS; Pratt N; Heath J; Schultz L; Sleve D; Carey GB; Zevotek N
    J Biol Chem; 2001 Feb; 276(5):3361-70. PubMed ID: 11058590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JNK1 physically interacts with WW domain-containing oxidoreductase (WOX1) and inhibits WOX1-mediated apoptosis.
    Chang NS; Doherty J; Ensign A
    J Biol Chem; 2003 Mar; 278(11):9195-202. PubMed ID: 12514174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms underlying WOX1 activation during apoptotic and stress responses.
    Chang NS; Doherty J; Ensign A; Lewis J; Heath J; Schultz L; Chen ST; Oppermann U
    Biochem Pharmacol; 2003 Oct; 66(8):1347-54. PubMed ID: 14555208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zfra affects TNF-mediated cell death by interacting with death domain protein TRADD and negatively regulates the activation of NF-kappaB, JNK1, p53 and WOX1 during stress response.
    Hong Q; Hsu LJ; Schultz L; Pratt N; Mattison J; Chang NS
    BMC Mol Biol; 2007 Jun; 8():50. PubMed ID: 17567906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo.
    Chang NS; Schultz L; Hsu LJ; Lewis J; Su M; Sze CI
    Oncogene; 2005 Jan; 24(4):714-23. PubMed ID: 15580310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement C1q activates tumor suppressor WWOX to induce apoptosis in prostate cancer cells.
    Hong Q; Sze CI; Lin SR; Lee MH; He RY; Schultz L; Chang JY; Chen SJ; Boackle RJ; Hsu LJ; Chang NS
    PLoS One; 2009 Jun; 4(6):e5755. PubMed ID: 19484134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WOX1 is essential for tumor necrosis factor-, UV light-, staurosporine-, and p53-mediated cell death, and its tyrosine 33-phosphorylated form binds and stabilizes serine 46-phosphorylated p53.
    Chang NS; Doherty J; Ensign A; Schultz L; Hsu LJ; Hong Q
    J Biol Chem; 2005 Dec; 280(52):43100-8. PubMed ID: 16219768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity.
    Shi L; Chen J; Yang J; Pan T; Zhang S; Wang Z
    Brain Res; 2010 Sep; 1352():255-64. PubMed ID: 20633539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MPP+-induced neuronal death in rats involves tyrosine 33 phosphorylation of WW domain-containing oxidoreductase WOX1.
    Lo CP; Hsu LJ; Li MY; Hsu SY; Chuang JI; Tsai MS; Lin SR; Chang NS; Chen ST
    Eur J Neurosci; 2008 Apr; 27(7):1634-46. PubMed ID: 18371080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gain of function of mutant TP53 in glioblastoma: prognosis and response to temozolomide.
    Wang X; Chen JX; Liu JP; You C; Liu YH; Mao Q
    Ann Surg Oncol; 2014 Apr; 21(4):1337-44. PubMed ID: 24248532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potential role of p53 and WOX1 in mitochondrial apoptosis (review).
    Chang NS
    Int J Mol Med; 2002 Jan; 9(1):19-24. PubMed ID: 11744990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adherens junction-associated protein 1 is a negative transcriptional regulator of MAGEA2, which potentiates temozolomide-induced apoptosis in GBM.
    Zeng L; Kang C; Di C; Fee BE; Rivas M; Lin J; Adamson DC
    Int J Oncol; 2014 Apr; 44(4):1243-51. PubMed ID: 24481586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas.
    Chiang MF; Chou PY; Wang WJ; Sze CI; Chang NS
    Front Oncol; 2013; 3():43. PubMed ID: 23459853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells.
    Lee SW; Kim HK; Lee NH; Yi HY; Kim HS; Hong SH; Hong YK; Joe YA
    Cancer Lett; 2015 May; 360(2):195-204. PubMed ID: 25681668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of WW domain proteins WWOX in development, prognosis, and treatment response of glioma.
    Liu SY; Chiang MF; Chen YJ
    Exp Biol Med (Maywood); 2015 Mar; 240(3):315-23. PubMed ID: 25432984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEK-ERK signaling dictates DNA-repair gene MGMT expression and temozolomide resistance of stem-like glioblastoma cells via the MDM2-p53 axis.
    Sato A; Sunayama J; Matsuda K; Seino S; Suzuki K; Watanabe E; Tachibana K; Tomiyama A; Kayama T; Kitanaka C
    Stem Cells; 2011 Dec; 29(12):1942-51. PubMed ID: 21957016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WOX1 is essential for UVB irradiation-induced apoptosis and down-regulated via translational blockade in UVB-induced cutaneous squamous cell carcinoma in vivo.
    Lai FJ; Cheng CL; Chen ST; Wu CH; Hsu LJ; Lee JY; Chao SC; Sheen MC; Shen CL; Chang NS; Sheu HM
    Clin Cancer Res; 2005 Aug; 11(16):5769-77. PubMed ID: 16115915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells.
    Hirose Y; Berger MS; Pieper RO
    Cancer Res; 2001 Mar; 61(5):1957-63. PubMed ID: 11280752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.